Wedbush Starts Rocket Pharmaceuticals (RCKT) at Outperform

December 30, 2024 6:42 AM EST Send to a Friend
Wedbush analyst Yun Zhong initiates coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login